Tag Archives: arthritis biosimilar fda approved

Arthritis Biosimilar

FDA Approves Third Biosimilar for Arthritis – Amjevita, a Biosimilar to Humira

The U.S. Food and Drug Administration (FDA) on Friday approved the third biosimilar to treat inflammatory types of arthritis – but, like the two that were previously approved, this one will not be available to patients until patent disputes are resolved.
Continue reading FDA Approves Third Biosimilar for Arthritis – Amjevita, a Biosimilar to Humira